Oxidative stress and diabetic vascular complications

Diabetes Care

Volumn 19, Issue 3, 1996, Pages 257-267

  Giugliano, Dario ^a   Ceriello, Antonio ^b   Paolisso, Giuseppe ^b  

^a NONE   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; HUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REVIEW;

EID: 0030048496     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.3.257     Document Type: Review

References (152)

1. Stamler J, Vaccaro O, Neaton JD, Wentworth D, the Multiple Risk Factor Intervention Trial Research Group: Diabetes, other risk factors and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444, 1993
2. Colwell JA: Vascular thrombosis in type II diabetes mellitus Diabetes 42:8-11, 1993
3. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
4. Chait A, Bierman EL Pathogenesis of macrovascular disease in diabetes In Joslin's Diabetes Mellitus Kahn CR, Weir G, Eds. Philadelphia, Lea & Febiger, 1994, p. 648-664
5. Pyörala K, Laakso M, Uusitupa M Diabetes and atherosclerosis, an epidemiological overview Diabetes Metab Rev 3:463-524, 1987
6. 1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes 41: 202-208, 1992
7. Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E, Pyörala K: Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type-2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36:1175-1184, 1993
8. Kuusisto J, Mykkänen L, Pyöräla K, Laakso M: NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43:960-967, 1994
9. Kannel WB, McGee DL: Diabetes and cardiovascular disease: the Framingham study JAMA 241:2035-2038, 1979
10. Klem R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 18:269-271, 1995
11. Beks PJ, Mackaay AJC, de Neeling JND, de Vries H, Bouter LM, Heine RJ: Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn Study. Diabetologia 38: 86-96, 1995
12. Moss SE, Klein R, Klein BE: The prevalence and incidence of lower extremity amputation in a diabetic population. Arch Intern Med 152 610-615, 1992
13. Bierman EL: Atherogenesis in diabetes. Atherioscler Thromb 12:647-656, 1992
14. Lyons TJ: Lipoprotein glycation and its metabolic consequences. Diabetes 41 (Suppl. 2):67-73, 1992
15. Chisolm GM, Irwin KC, Penn MS Lipoprotein oxidation and lipoprotein-induced cell injury in diabetes. Diabetes 41 (Suppl. 2):61-66, 1992
16. Bowie A, Owens D, Collins P, Johnson A, Tomkin GH: Glycosylated low density lipoprotein is more sensitive to oxidation implications for the diabetic patients? Atherosclerosis 102:63-67, 1993
17. Morel DW, Chisolm GM: Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J Lipid Res 30:1827-1834, 1989
18. Lyons TJ, Klem RL, Baynes JW, Stevenson HC, Lopez-Virella MF: Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by low density lipoproteins from type 1 (insulin-dependent) diabetic patients the influence of nonenzymatic glycosylation of low-density lipoproteins Diabetologia 30:916-923, 1987
19. Ceriello A: Coagulation activation in diabetes mellitus: the role of hyperglycemia and therapeutic prospects Diabetologia 36:1119-1125, 1993
20. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315-1321, 1988
21. Dyer DG, Dunn JA, Thorpe SR, Bailie KE, Lyons TJ, McCance DR, Baynes JW: Accumulation of Maillard reaction products in skin collagen in diabetes and aging J Clin Invest 91 2463-2469, 1993
22. Beisswenger PJ, Makita Z, Curphey TJ, Moore LL, Jean S, Brinck-Johnsen T, Bucala R, Vlassara H: Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes 44:824-829, 1995
23. Cross CE, Halliwell B, Borish ET, Pryor WA, Ames BN, Saul RL, McCord JM, Harman D: Oxygen radicals and human disease. Ann Intern Med 107:526-545, 1987
24. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 40.405-412, 1991
25. Hunt JV, Dean RT, Wolff SP: Hydroxyl radical production and autoxidative glycosylation: glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem J 256:205-212, 1988
26. Cameron NE, Cotter MA: Neurovascular dysfunction in diabetic rats: potential contribution of autoxidation and free radicals examined using transition metal chelating agents. J Clin Invest 96:1159-1163, 1995
27. Hohman TC, Beg MA: Diabetic complications progress in the development of treatments. Exp Opin Invest Drugs 3 1041-1049, 1994
28. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, Van Den Enden M, Kilo C, Tilton RG: Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42: 801-813, 1993
29. 2 in human umbilical vein endothelial cells cultured in high glucose medium. Diabetologia 37:264-269, 1994
30. 2 in high-glucose medium. Diabetes 44:520-526, 1995
31. Yoshida K, Hirokawa J, Tagami S, Kawakami Y, Urata Y, Kondo T Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux. Diabetologia 38:201-210, 1995
32. Low PA, Tuck RR, Dyck PJ, Schmelzer JD, Yao JK: Prevention of some electrophysiological and biochemical abnormalities with oxygen supplementation in experimental diabetic neuropathy. Proc Natl Acad Sci USA 81:6894-6898, 1988
33. Smith WL. Prostaglandin biosynthesis and its compartmentation in vascular smooth muscle and endothelial cells. Annu Rev Physiol 48:251-262, 1986
34. McCord JM: Oxygen-derived free radicals in postischemic tissue injury N Engl J Med 312:159-163, 1985
35. Cameron NE, Cotter MA The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabetes Metab Rev 10: 189-224, 1993
36. Oda A, Bannai C, Yamaoka T, Katori T, Matsushima T, Yamashita K: Inactivation of Cu,Zn-superoxide dismutase by in vitro glycosylation and in erythrocytes of diabetic subjects. Horm Metab Res 26: 1-4, 1994
37. Crouch R, Kimsey G, Priest DG, Sarda A, Buse MG: Effect of streptozotocin on erythrocyte and retinal superoxide dismutase. Diabetologia 15:53-57, 1978
38. Matkovics B, Varga S-I, Szabo L, Witas H: The effect of diabetes on the activities of the peroxide metabolism enzymes. Horm Metab Res 14:77-79, 1982
39. Wohaieb SA, Godin DV. Alterations in tissue antioxidant systems in the spontaneously diabetic (BB Wistar) rat Can J Physiol Pharmacol 65 2191-2195, 1987
40. Pieper GM, Jordan M, Dondlinger LA, Adams MB, Roza AM Peroxidative stress in diabetic blood vessels. Diabetes 44: 884-889, 1995
41. Wohaieb SA, Godin DV: Alterations in free radical tissue-defense mechanisms in streptozotocin-induced diabetes in rat: effects of insulin treatment. Diabetes 36 1014-1018, 1987
42. Nagasaka Y, Fujii S, Kaneko T: Effects of high glucose and sorbitol pathway on lipid peroxidation of erythrocytes Horm Metab Res 21:275-276, 1989
43. Uzel N, Sivas A, Uysal H, Kawakami Y, Oz H: Erythrocyte lipid peroxidation and glutathione-peroxidase activities in patients with diabetes mellitus. Horm Metab Res 19:89-90, 1987
44. Fujiwara Y, Kondo T, Murakami K: Decrease of the inhibition of lipid peroxidation by glutathione dependent system in erythrocytes of non-insulin dependent diabetics. Klin Whochenschr 67: 336-341, 1989
45. Jain SK, McVie R: Effect of glycemic control, race (white versus black), and duration of diabetes on reduced glutathione content in erythrocytes of diabetic patients. Metabolism 43:306-309, 1994
46. Nishigaki I, Hagihara M, Tsunekawa H, Maseki M, Yagi K: Lipid peroxide levels of serum lipoprotein fractions of diabetic patients. Biochem Med 25:373-378, 1981
47. Altomare E, Vendemiale G, Chicco D, Procacci V, Cirelli F: Increased lipid peroxidation in type 2 poorly controlled diabetic patients. Diabete Metab 18:264-271, 1992
48. Jennings PE, Jones AF, Florkowski CM, Lunec J, Barnett AH: Increased diene conjugates in diabetic subjects with microangiopathy. Diabetic Med 4:452-456, 1987
49. MacRury SM, Gordon D, Wilson R, Bradley H, Gemmell CG, Paterson JR, Rumley AG, MacCuish AC: A comparison of different methods of assessing free radical activity in type 2 diabetes and peripheral vascular disease. Diabetic Med 10: 331-335, 1993
50. Stringer MD, Görög PG, Freeman A, Kakkar W: Lipid peroxides and atherosclerosis. Br Med J 298:281-284, 1989
51. Griesmacher A, Kindhauser M, Anden SE, Schreiner W, Toma C, Knoebl P, Pietschmann P, Prager R, Schnack R, Schernthaner G, Mueller MM: Enhanced serum levels of thiobarbituric-acid reactive substances in diabetes mellitus Am J Med 98:469-475, 1995
52. Haffner SM, Agil A, Mykkanen L, Stem MP, Jialal I: Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance and NIDDM. Diabetes Care 18:646-653, 1995
53. Pryor WA, Godberg SS: Noninvasive measures of oxidative stress status in humans. Free Rad Biol Med 10:177-184, 1991
54. Ghiselli A, Laurenti O, De Mattia G, Maiani G, Ferro-Luzzi A: Salicylate hydroxylation as an early marker of in vivo oxidative stress in diabetic patients. Free Rad Biol Med 13:621-626, 1992
55. Ceriello A, Giugliano D, Quatraro A, Dello Russo P, Lefebvre PJ: Metabolic control may influence the increased superoxide generation in diabetic serum. Diabetic Med 8:540-542, 1991
56. Dandona P, Thusu K, Cook S, Snyder B, Nicotera T: Oxidative damage to deoxyribonucleic acid (DNA) in insulin-dependent diabetes mellitus (Abstract) Diabetes 43 (Suppl. 1):35A, 1994
57. Lorenzi M, Montisano DF, Toledo S, Barneux A: High glucose induces DNA damage in cultured human endothelial cells J Clin Invest 77:322-325, 1986
58. Chari SN, Nath N, Ratht AB: Glutathione and its redox system in diabetic polymorphonuclear leukocytes. Am J Med Sci 287:14-15, 1984
59. Jennings PE, Chirico S, Jones AF, Lunec J, Barnett AH: Vitamin C metabolites and microangiopathy in diabetes mellitus. Diabetes Res 6:151-154, 1987
60. Karpen CW, Cataland S, D'Orisio TM, Panganamala RV: Production of 12 HETE and vitamin E status in platelets from type 1 human diabetic subjects. Diabetes 34:526-531, 1985
61. Paolisso G, D'Amore A, Balbi V, Volpe C, Galzerano D, Giugliano D, Sgambato S, Varricchio M, D'Onofrio F: Plasma vitamin C affects glucose homeostasis in healthy subjects and in non-insulin-dependent diabetics. Am J Physiol 266: E261-E268, 1994
62. Oberley LW: Free radicals and diabetes. Free Rad Biol Med 5:113-124, 1986
63. Halliwell B, Gutteridge JMC. The antioxidants of human extracellular fluids. Arch Biochem Biophys 280:1-8, 1990
64. Stocks J, Gutteridge JMC, Sharp RJ, Dormandy TL: Assay using brain homogenate for measuring the antioxidant activity of biological fluid. Clin Sci Mol Med 47:215-222, 1974
65. Asayama K, Uchida N, Nakane T, Hayashibe H, Dobashi K, Amemiya S, Kato K, Nakazawa S: Antioxidants in the serum of children with insulin-dependent diabetes mellitus. Free Rad Biol Med 15: 597-602, 1993
66. Tsai EC, Hirsch IB, Brunzell JD, Alan C: Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 43:1010-1014, 1994
67. Santini SA, Cotroneo P, Ghirlanda G, Giardina B, Manto A, Marra G, Magnani P, Tilli P, Mordente A. Serum antioxidant in diabetes mellitus (Abstract). Diabetoiogia 38 (Suppl. 1):A41, 1995
68. Fondelli C, Signorim AM, Borgogni L, Gragnoli G: Tolrestat and superoxide anion production in type 2 diabetic patients (Abstract) Diabetologia 36 (Suppl. 1) A204, 1993
69. Masson EA, Boulton AJM: Aldose reductase inhibitors in the treatment of diabetic neuropathy: a review of the rationale and clinical evidence. Drugs 39: 190-202, 1990
70. Santiago JV, Sonksen PH, Boulton AJM, Macleod A, Beg M, Bochenek W, Graepel CJ, Gonen B, Tolrestat Study Group: Withdrawal of the aldose reductase inhibitor tolrestat in patients with diabetic neuropathy: effect on nerve function. J Diabetic Complications 7:170-178, 1993
71. Giugliano D, Marfella R, Quatraro A, DeRosa N, Salvatore T, Cozzolino D, Ceriello A, Torella R: Tolrestat for mild diabetic neuropathy a 52-week, randomized, placebo-controlled trial. Ann Intern Med 118-7-11, 1993
72. Giugliano D, Acampora R, Marfella R, Di Maro G, De Rosa N, Misso L, Ceriello A, Quatraro A, D'Onofrio F: Tolrestat in the primary prevention of diabetic neuropathy. Diabetes Care 18:536-541, 1995
73. Vallance P, Collier J, Moncada S: Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet ii:997-1000, 1989
74. Cohen RA: Dysfunction of vascular endothelium in diabetes mellitus. Circulation 87 (Suppl. V):67-76, 1993
75. Harrison DG: Endothelial dysfunction in the coronary microcirculation: a new clinical entity or an experimental finding?; Clin Invest 91:1-2, 1993
76. Tesfamariam B, Brown ML, Deykin D, Cohen RA: Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest 85:929-932, 1990
77. Saenz de Tejada IS, Goldstein I, Azadzoi K, Krane RJ, Cohen RA: Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 320:1025-1030, 1989
78. Tesfamariam B, Cohen RA: Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 263:H321-H326, 1992
79. Plane F, Jacobs M, McManus D, Bruckdorfer KR: Probucol and other antioxidants prevent the inhibition of endothelium-dependent relaxation by low density lipoproteins. Atherosclerosis 103: 73-79, 1993
80. Keaney JF Jr, Xu A, Cunningham D, Jackson T, Frei B, Vita JA: Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation J Clin Invest 95:2520-2529, 1995
81. Anderson TJ, Meradith IT, Yeung AC, Frei B, Selwyn AP, Ganz P: The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 332: 488-493, 1995
82. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Nad Acad Sci USA 87:1620-1624, 1990
83. 2 receptor antagonists inhibit endothelium-dependent contractions. Hypertension 15:699-703, 1990
84. Ceriello A, Quatraro A, Caretta F, Varano R, Giugliano D: Evidence for a possible role of oxygen free radicals in the abnormal functional arterial vasomotion in insulin-dependent diabetes. Diabete Metab 16:318-322, 1990
85. Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM, Currie MG, Corbett JA, McDaniel ML, Williamson JR: Prevention of diabetic vascular dysfunction by guanidines. Diabetes 42:221-232, 1993
86. Bucala R, Tracey KJ, Cerami A: Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 87: 432-438, 1991
87. Bohlen HG, Lash JM: Topical hyperglycemia rapidly suppresses EDRF-mediated vasodilation of normal rat arterioles. Am J Physiol 265:H219-H225, 1993
88. 2. Am J Physiol 257:H1327-H1333, 1989
89. Tesfamariam B: Selective impairment of endothelium-dependent relaxation by prostaglandin endoperoxides. J Hypertens 12:41-47, 1994
90. Gupta S, Tieken K, Ruderman N: Inhibition of nitric oxide synthase activity by hyperglycemia in endothelial cells. Diabetes 43 (Suppl. 1):100A, 1994
91. Weisbrod RM, Brown ML, Cohen RA: Effect of elevated glucose on cyclic GMP and eicosanoids produced by porcine aortic endothelium. Arterioscler Thromb 13:915-923, 1993
92. Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL, Sweetland MA, Lancaster JR Jr, Williamson JR, McDaniel ML: Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41: 552-556, 1992
93. Picard S, Parthasarathy S, Fruebis J, Witztum JL: Aminoguanidine inhibits oxidative modification of low density lipoprotein and the subsequent increase in uptake by the macrophage scavenger receptor. Proc Natl Acad Sci USA 89: 6876-6880, 1992
94. Chin JH, Azhar S, Hoffman BB: Inactivation of endothelium-derived relaxing factor by oxidized proteins. J Clin Invest 89:10-18, 1992
95. +)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J Clin Invest 94:853-859, 1994
96. Marfella R, Verrazzo G, Acampora R, La Marca C, Giunta R, Lucarelli C, Paolisso G, Ceriello A, Giugliano D: Glutathione reverses systemic hemodynamic changes induced by acute hyperglycemia in healthy subjects. Am J Physiol 268: E1167-E1173, 1995
97. Ceriello A, Giugliano D, Quatraro A, Lefebvre PJ: Antioxidants show an antihypenensive effect in diabetic and hypertensive subjects. Clin Sci 81:739-742, 1991
98. Stout RW: Glucose inhibits replication of cultured human endothelial cells. Diabetologia 23:436-439, 1982
99. Curcio F, Ceriello A: Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: new insights on the pathophysiological mechanisms of diabetic vascular complications. In Vitro Cell Dev Biol 28A: 787-790, 1992
100. Ceriello A, Curcio F, Colombatti A, Dello Russo P, Pegoraro I, Giugliano D: Hyperglycemia-induced endothelial cell alterations are reversed by antioxidants (Abstract) Diabetologia 35 (Suppl. 1): 103A, 1992
101. Pegoraro I, Dello Russo P, Falletti E, Perrella F, Cianfraglia A, Gatto V, Curcio F: Antioxidants inhibit the high glucose-dependent increase of PDGF secretion in human endothelial cells (Abstract). J Endocrinol Invest 17 (Suppl. 2):75A, 1994
102. Calver AC, Collier JG, Vallance PJT: Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 90:2548-2554, 1992
103. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT. Henry WR, Andrews JW: Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35:771-776, 1992
104. Johnstone MT, Creager SJ, Kathleen MS, Cusco JA, Lee BK, Creager MA: Impaired endothelium-dependent vasodilatation in patients with insulin-dependent diabetes mellitus. Circulation 88 2510-2516, 1993
105. Elliott TG, Cockcroft JR, Groop PH, Viberti GC, Ritter JM: Inhibition of nitric oxide synthesis in forearm vasculature on insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci 85: 687-693, 1993
106. Halkin A, Benjamin N, Doktor HS, Todds D, Viberti G, Ritter JM: Vascular responsiveness and cation exchange in insulin dependent diabetes. Clin Sci 81:223-232, 1991
107. Smits P, Kapma JA, Jacobs MC, Lutterman J, Thien T Endothelium-dependent vascular relaxation in patients with type-1 diabetes mellitus. Diabetes 42: 148-153, 1993
108. G-monomethyl-L-arginine of vasodilator effects of acetylcholine and methacholine in human forearm. Br J Pharmacol 110:736-738, 1993
109. Chowienczyk PJ, Cockcroft JR, Ritter JM Blood flow responses to intraarterial acetylcholine in man: effects of basal flow and conduit vessel length. Clin Sci 87:45-51, 1994
110. Lüscher TF, Vanhoutte PM. The Endothelium: Modulator of Cardiovascular Function. Boca Raton, CRC 1990, p. 1-228
111. Angus JA, Lew MJ: Interpretation of the acetylcholine test of endothelial cell dysfunction in hypertension. J Hypertens 10 (Suppl. 7)S179-S186, 1992
112. McVeigh G, Brennan H, Hayes R, Johnston D: Primary nitrate tolerance in diabetes mellitus. Diabetologia 37:115-117, 1994
113. Zenere BM, Arcari G, Saggiani F, Rossi L, Muggeo M, Lechi A: Noninvasive detection of functional alterations of the arterial wail in IDDM patients with and without microalbuminuria Diabetes Care 18:975-982, 1995
114. Fung HL, Chung SJ, Bauer JA, Chong S, Kowaluk EA: Biochemical mechanism of organic nitrate action. Am J Cardiol 70: 4B-10B, 1992
115. Giugliano D, Marfella R, Verrazzo G, Acampora R, Donzella C, Quatraro A, Coppola L, D'Onofrio F: Abnormal rheologic effects of glyceryl trinitrate in patients with non-insulin-dependent diabetes mellitus and reversal by antioxidants. Ann Intern Med 123:338-343, 1995
116. Münzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG: Evidence for enhanced superoxide anion production in nitrate tolerance: a novel mechanism underlying tolerance and cross-tolerance. J Clin Invest 95:187-194, 1995
117. Tooke JE Microvascular hemodynamics in diabetes mellitus Clin Sci 70:119-125, 1986
118. Parving HH, Kastrup H, Smidt UM, Andersen AR, Feldt-Rasmussen B, Christiansen JS: Impaired autoregulation of glomerular filtration rate of type-1 (insulin-dependent) diabetic patients with nephropathy Diabetologia 27:547-552, 1984
119. Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali-R: Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 42:1017-1025, 1993
120. McNally PG, Watt PAC, Rimmer T, Burden AC, Hearnshaw JR, Thurston H: Impaired contraction and endothelium dependent relaxation in isolated resistance vessels from patients with insulin-dependent diabetes. Clin Sci 87:31-36, 1994
121. Lowenstein CJ, Snyder SH: Nitric oxide, a novel biologic messenger. Cell 70:705-707, 1992
122. Cooke JP, Tsao PS. Cytoprotective effects of nitric oxide. Circulation 88: 2451-2454, 1993
123. Cameron NE, Cotter MA, Archibald V, Dines KC, Maxfield EK: Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non diabetic and streptozotocin-dtabetic rats. Diabetologia 37:449-459, 1994
124. Nagamatsu M, Nickander KK, Schmelzer JD, Raya A, Wittrock DA, Tritschler H, Low PA Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 18:1160-1167, 1995
125. Kanwar YS, Liu ZZ, Kashihara N, Wallner EI: Current status of the structural and functional basis of glomerular filtration and proteinuria. Semin Nephrol 11: 390-413, 1991
126. Kashihara N, Watanabe Y, Makino H, Wallner EI, Kanwar YS: Selective decreased de novo synthesis of glomerular proteoglycans under the influence of reactive oxygen species. Proc Natl Acad Sci USA 89:6309-6313, 1992
127. Tada H, Kuboki K, Isogai S: Impaired catalase activity and altered glutathione redox cycle in isolated glomeruli from STZ-induced diabetic rats (Abstract). In Procedings of the 15th International Diabetes Federation, Kobe, Japan, November 6-11, 1994 Brussels, International Diabetes Federation, 1994, p 131A
128. Kern TS, Kowluru R, Engerman RL Correction of retinal dysfunction in diabetic rats and galactosemic rats by antioxidants, calcium channel blocker or aldose reductase inhibitor (Abstract). In Proceedings of the 15th International Diabetes Federation, Kobe, Japan, November 6-11, 2994 Brussels. International Diabetes Federation, 1994, p. 369A
129. Madar Z, Oren P, Pollack A: Inhibitory effect of lycopen on cataract development in diabetic sand rats and galactosemic rats (Abstract) Diabetologia 38 (Suppl. 1):A276, 1995
130. Handelman GJ, Kilic F, Trevithick J, Packer L. Stereospecific protection by alpha-lipoic acid in diabetic cataract modeled in vitro (Abstract). Diabetologia 38 (Suppl 1). A277, 1995
131. Grattagliano I, Vendemiale G, Micelli-Ferrari T, Boscia F, Signorile A, Didonna D, Cordia L, Altomare E: Abnormal protein redox status and impairment of antioxidant defence in lens and vitreous of diabetic subjects (Abstract). Diabetologia 38 (Suppl. 1):A276, 1995
132. Cerutti PA: Prooxidant states and tumor promotion. Science 227:375-381, 1985
133. Ceriello A, Dello Russo P, Curcio F, Pegoraro I, Giugliano D, Amstad P, Cerutti PA: Antioxidant defences are induced by hyperglycemia in cultured human endothelial cells (Abstract). Diabetologia 36 (Suppl. 1):203A, 1993
134. Nishimura C, Saito T, Ito T, Omon Y, Tanimoto T: High levels of aldose reductase and diabetic retinopathy in NIDDM patients. Diabetologia 37:328-330, 1994
135. Yamaoka T, Nishimura C, Yamashita K, Itakura M, Yamada T, Fujimoto J, Kodai Y: Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA. Diabetologia 38: 255-261, 1995
136. Malaisse WJ, Malaisse-Lagae F, Sener A, Pipeleers DG: Determinants of the selective toxicity of alloxan to the pancreatic B cell. Proc Natl Acad Sci USA 79:927-930, 1982
137. Rabinovitch A, Suarez WL, Thomas PD, Strynadka K, Simpson I: Cytotoxic effects of cytokines on rat islets: evidence for involvement of free radicals and lipid peroxidation. Diabetologia 35:409-413, 1992
138. Kroncke KD, Kolb-Bachofen V, Berschick B, Burkart V, Kolb H: Activated macrophages kill pancreatic islet cells via arginine-dependent nitric oxide generation. Biochem Biophys Res Commun 175:752-758, 1991
139. Pozzilh P, Visalli N, Signore A, Baroni ME, Buzzetti R, Cavallo MG, Boccuni ML, Fava D, Gragnoli C, Andreani D, Lucentini I, Metteoli MC, Crinö A, Cicconetti CA, Teodonio C, Paci F, Amoretti R, Pisano L, Pennafina MG, Santopadre G, Marozzi G, Mukan G, Suppa MA, Campea L, De Mattia GC, Cassone Faldetta M, Marietti G, Perrone F, Greco AV, Ghirlanda G. Double blind trial of nicotinamide in recent onset IDDM (the Imdiab III study). Diabetologia 38:848-852, 1995
140. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC: Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328:1450-1456, 1993
141. Stampfer MJ, Hennekens CH, Manson JE, Rosner GA, Willett WC: Vitamin E consumption and the risk of coronary heart disease in women N Engl J Med 328 1444-1449, 1993
142. Morris DL, Kritchevsky SB, Davis CE: Serum carotenoids and coronary heart disease: the Lipid Research Clinics Coronary Primary Prevention Trial and Follow-up Study JAMA 272:1439-1441, 1994
143. Trout DL: Vitamin C and cardiovascular nsk factors. Am J Clin Nutr 53:322S-325S, 1991
144. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group: The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330:1029-1035, 1994
145. Ceriello A, Giugliano D, Quatraro A, Donzella C, DiPalo G, Lefebvre PJ. Vitamin E reduction of protein glycosylation in diabetics: new prospect for prevention of diabetic complications? Diabetes Care 14:68-72, 1991
146. Paolisso G, D'Amore A, Giugliano D, Ceriello A, Varrichio M, D'Onofrio F: Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am J Clin Nutr 57 650-656, 1993
147. Paolisso G, D'Amore A, Galzerano D, Balbi V, Giugliano D, Varriccho M, D'Onofrio F. Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type-II diabetic patients Diabetes Care 16: 1433-1437, 1993
148. Coppola L, Grassia A, Giunta R, Verrazzo G, Cava B, Tirelli A, D'Onofrio F: Glutathione (GSH) improves haemostatic and haemorheological parameters in atherosclerotic subjects. Drugs Exp Clin Res 18;493-498, 1992
149. Paolisso G, Gambardella A, Giugliano D, Galzerano D, Amato L, Volpe C, Balbi V, Varricchio M, D'Onofrio F: Chronic intake of pharmacological doses of vitamin E might be useful in the therapy of elderly patients with coronary heart disease. Am J Clin Nutr 61:848-852, 1995
150. Gey KF, Moser UK, Jordan P, Stähelin HB, Eichholzer M, Lüdiu F: Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C Am J Clin Nutr 57 (Suppl.): 787S-97S, 1993
151. Hertog MGL, Feskens EJM, Hollman PGH, Katan MB, Kromhout D: Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Study. Lancet 342:1007-1011, 1993
152. 2-isoprostanes) in smokers: smoking as a cause of oxidative damage. N Engl J Med 332:1198-1203, 1995